Oneness Biotech Statistics

Total Valuation

Oneness Biotech has a market cap or net worth of TWD 28.83 billion. The enterprise value is 22.71 billion.

Market Cap	28.83B
Enterprise Value	22.71B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Oneness Biotech has 478.03 million shares outstanding. The number of shares has increased by 0.97% in one year.

Current Share Class	n/a
Shares Outstanding	478.03M
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	7.64%
Owned by Institutions (%)	6.06%
Float	308.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	244.44
PB Ratio	2.25
P/TBV Ratio	2.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.49
EV / Sales	192.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-57.46

Financial Position

The company has a current ratio of 39.87, with a Debt / Equity ratio of 0.03.

Current Ratio	39.87
Quick Ratio	38.90
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-1.03
Interest Coverage	-113.02

Financial Efficiency

Return on equity (ROE) is -8.45% and return on invested capital (ROIC) is -4.83%.

Return on Equity (ROE)	-8.45%
Return on Assets (ROA)	-4.68%
Return on Invested Capital (ROIC)	-4.83%
Return on Capital Employed (ROCE)	-8.06%
Revenue Per Employee	2.74M
Profits Per Employee	-27.10M
Employee Count	43
Asset Turnover	0.01
Inventory Turnover	0.46

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.80% in the last 52 weeks. The beta is 1.71, so Oneness Biotech's price volatility has been higher than the market average.

Beta (5Y)	1.71
52-Week Price Change	-56.80%
50-Day Moving Average	71.88
200-Day Moving Average	112.87
Relative Strength Index (RSI)	43.82
Average Volume (20 Days)	2,378,108

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Oneness Biotech had revenue of TWD 117.93 million and -1.17 billion in losses. Loss per share was -2.44.

Revenue	117.93M
Gross Profit	63.03M
Operating Income	-1.09B
Pretax Income	-1.15B
Net Income	-1.17B
EBITDA	-681.01M
EBIT	-1.09B
Loss Per Share	-2.44

Full Income Statement

Balance Sheet

The company has 7.02 billion in cash and 406.35 million in debt, giving a net cash position of 6.61 billion or 13.83 per share.

Cash & Cash Equivalents	7.02B
Total Debt	406.35M
Net Cash	6.61B
Net Cash Per Share	13.83
Equity (Book Value)	12.80B
Book Value Per Share	25.73
Working Capital	7.11B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -345.58 million and capital expenditures -49.71 million, giving a free cash flow of -395.28 million.

Operating Cash Flow	-345.58M
Capital Expenditures	-49.71M
Free Cash Flow	-395.28M
FCF Per Share	-0.83

Full Cash Flow Statement

Margins

Gross Margin	53.45%
Operating Margin	-920.96%
Pretax Margin	-974.96%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Oneness Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.97%
Shareholder Yield	-0.97%
Earnings Yield	-4.04%
FCF Yield	-1.37%

Dividend Details

Stock Splits

The last stock split was on July 26, 2024. It was a forward split with a ratio of 1.049967976.

Last Split Date	Jul 26, 2024
Split Type	Forward
Split Ratio	1.049967976

Scores

Oneness Biotech has an Altman Z-Score of 48.44.

Altman Z-Score	48.44
Piotroski F-Score	n/a